GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innopharmax Inc (ROCO:4172) » Definitions » YoY EPS Growth

Innopharmax (ROCO:4172) YoY EPS Growth : -36.28% (As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Innopharmax YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Innopharmax's YoY EPS Growth for the quarter that ended in Jun. 2024 was -36.28%.

Innopharmax's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was NT$-0.45.

Innopharmax YoY EPS Growth Historical Data

The historical data trend for Innopharmax's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innopharmax YoY EPS Growth Chart

Innopharmax Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.70 54.07 -89.61 -11.72 35.28

Innopharmax Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.30 -6.46 41.01 30.19 -36.28

Innopharmax YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Innopharmax's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-0.765--1.182)/ | -1.182 |
=35.28 %

Innopharmax's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EPS Growth (Q: Jun. 2024 )
=(Earnings per Share (Diluted) (Q: Jun. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(-0.447--0.328)/ | -0.328 |
=-36.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innopharmax YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Innopharmax's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Innopharmax Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innopharmax Inc (ROCO:4172) » Definitions » YoY EPS Growth
Comparable Companies
ROCO:1780 ROCO:4127 ROCO:6496 ROCO:6817 ROCO:6677 TPE:3054 ROCO:8432 ROCO:4117 ROCO:1796 ROCO:6483 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 22, Lane 478, Ruiguang Road, 9th Floor, Neihu District, Taipei, TWN, 11492
Website
http://www.innopharmax.com
Innopharmax Inc is a Taiwan based specialty pharmaceutical company. It is focused on the development and commercialization of products for the treatment of oncology and specialty. The company's products include anti-infection agents, contrast agents, oncology agents, immunological agents, drugs for rare diseases and others.

Innopharmax Headlines

No Headlines